To cite this paper use one of the standards below:
This study aimed the in vivo anticancer and anti-inflammatory evaluation of the fraction F2, the most active fraction obtained from the ethanolic extract of M. aquatica aerial parts. Cultivated in a greenhouse, the M. aquatica (exsicate CM 19) aerial parts were collected in May 2017, at CPQBA/Unicamp. The ethanolic extract was obtained by dynamic maceration (3 x 90 min) of frozen ground aerial parts with ethanol (plant:solvent 1:6, w/v). By filtrating liquid chromatography and TLC analysis, 9 groups (F1-9) of fractions were obtained and tested in the antiproliferative in vitro assay, being the F2 selected to in vivo studies. All procedures were approved (4617-1) the CEUA/Unicamp. Using the acute oral toxicity model, the maximum tolerated dose (MTD) was determined in female mice Swiss (n = 5/group, 8 weeks) treated by gavage with PBS (10 ml/Kg) or F2 (50; 25 and 12.5 mg/kg) being the animals observed during 14 days. The anticancer activity was assessed through the solid Ehrlich carcinoma model, in female mice Balb/c (n = 8/group). In the third day after the tumor inoculation, the animals were randomly distributed into the experimental groups [vehicle (PBS, v.o., 10 mL/kg), F2 (v.o., 7.5; 15 and 30 mg/kg) or doxorubicin (i.p., 3 mg/kg)] and treated each 3 days during 12 days. Besides, one group received neither tumor inoculum nor treatment (satellite group) to evidence the deleterious effects of the Ehrlich tumor. At the 12th day, the relative weights of the tumor and some organs were determined after the animals’ euthanasia. Finally, using the carrageen-induced paw edema model, the anti-inflammatory activity was evaluated in female mice Balb/C (n = 10/group) randomly treated by gavage with PBS (10 mL/kg), dexamethasone (25 mg/kg) or F2 (50; 25 and 12.5 mg/kg). One hour after treatment, all animals received the carrageen injection (3%, Cg) into the right hind paw. The paw edema was measured before (0 h, basal) and after (2, 4, 6 24, 48 and 72 hours) Cg injection using one hydropletismometer (Ugo Basile® 37140). The carrageen-induced edema was calculated as the difference between the measurements at basal and each experimental time, expressed in percentage. Expressed as average ± SD, the statistical significance of the results was analyzed by ANOVA followed by Dunnett’s test in comparison to the vehicle group. None clinical signal of toxicity was observed after the treatment with F2. So, the dose of 50 mg/kg was assumed as the maximum dose tolerated. Considering the repetitive treatment in the solid Ehrlich tumor model, the higher dose chosen corresponded to 60% of MTD. In these conditions, F2 did not affect the tumor growth besides a slight significant (p<0.05) reduction in the relative liver weight in comparison to the vehicle group. In addition, F2 did not show anti-inflammatory effect under the experimental. This way, although the low toxicity evidences of F2 when administered in vivo, it was not possible to prove the anticancer effect of F2.
Financial support: CNPq. Processo: 132207/2017-6; CAPES-PROEX.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper